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The results from the need to develop methodologies for performing cost analysis in developing countries, principally in
the region of Latin America, were studied. It, furthermore, serves to generate knowledge from an economic evaluation
in order to support decision-making related to the organization of health systems, particularly in the efficient use of
resources which are allocated for the provision of medical services. Two chronic diseases (breast cancer and cardiac
valve disease) and two infections (enteritis and bronchopneumonia) were selected for the study. The results
recommend the use of a valid methodology for economic cost analysis of any disease to be studied and the use of this
information in the decision-making process.
Health care costs. Cost control. Health economics.
Introduction
It is evident to all that the extraordinary
increase in the cost of health services and conse-
quently the necessary increase in expenditure in
recent years has produced multiple inequities in
the governments of developing countries and over
all among the planners, managers and health poli-
cy makers4. The demand for health care does not
diminish; It become ever more diversified. The
elevated cost of distinct alternatives of action in
this period of economic recession has imposed a
heavy burden on the national budgets which the
governments are trying to reduce17.
In the process of planning, it is necessary to
recognize the importance of applying economic
analyses to the health sector. During the first
Ibero-American Public Health Conference in
August 1988, a scheme of interinstitutional coope-
ration was created which eventually led to an
advance in the promotion of sectorial leadership.
In order to complete this task, one of the areas ana-
lyzed since the last World Assembly of Health,
was precisely that which promoted the under-
standing of the interrelations between economics
and health8,18.
Economic issues are gaining growing impor-
tance in the field of medical care. They prove to be
increasingly important in measuring the increased
participation of the health sector in the gross
domestic product27. Health workers must be aler-
ted to the changes that are coming about and the
economic forces that they influence, such as rela-
ted jobs that exert a considerable impact on the
employment market24.
In the case of Latin America, and particularly
in Brazil, an important force has arisen, in recent
years, with a view to satisfy the health needs of the
population. Nevertheless, to date, according to
official data, there exist a considerable percentage
of the population which lack health services, and
which fundamentally affect, the mass of the popu-
lation located outside the urban areas and within
the low income areas21.
According to the understanding of the econom-
ic meaning of efficiency, if patients were not trea-
ted at or refered to a superior level of care, if this
were possible, their diagnosis and treatment would
be adequately provided at an lower level2,25.
The problem results from the lack of tech-
niques and procedures compounded by the lack of
parameters for the measurement of productivity,
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costs, and procedures for interaction among di-
fferent levels of care; these factors together trans-
lates into a health system without an adequate
basis for the management and evaluation of its
interaction and efficiency. On the other hand, in
view of the health conditions prevalent in the
majority of Latin American countries it is neces-
sary to take the trends of the change in the epi-
demiological patterns in developing countries as a
basis for analysis11. The theory of these epidemio-
logical patterns assumes that the trends of morta-
lity correspond to certain changes in the incidence
of diseases, presenting a pattern of mixed morbi-
dity and mortality13.
This phenomenon emphasizes that, first, the
group of infectious diseases is in decline but has
not disappeared and has also given rise to other ill-
nesses, such as AIDS; secondly, chronic-degener-
ative illnesses and accidents have increased; third-
ly, permanent conditions include congenital mal-
formations and perinatal problems6,10.
In this sense, chronic diseases and accidents
have progressed to occupy an important role
among the causes of morbidity/mortality; even-
though the importance of the infectious disease
persists in the mixed pattern still present in the
principal causes of morbidity/mortality.
In economic terms, the meaning of changes in
the epidemiological patterns specific to develo-
ping countries means an increase in the demand of
care for costly diseases (treatment of chronic
degenerative diseases and accidents) that will
compete with the budget allocated for the trea-
tment of infectious-contagious diseases even if
these are incurable7,16,20.
Examples of budget competition are cited in
the studies of Rice, Hodgsone, and Kopstein who
analyzed the direct costs (derived from the provi-
sion of services) in the United States for the treat-
ment of heart disease which absorb 1.25% of the
GDP and the indirect costs (productivity losses
due to morbidity and premature death) account for
2% of the GDP23. Based on the previous percen-
tage and taking into consideration the increase of
cardiovascular disease in Latin America, one can
say that these diseases per se would be demanded
in the future. Given the actual conditions of health
expenditure, more than one third of the necessary
expenses are required to be budgeted to treat them.
The growing demand for care is resulting in a
process of economic crises and of low participa-
tion of health expenditure within the gross domes-
tic product. In other words, the growing demand
for care faces an economic barrier that will limit its
resolution11,26. Nevertheless, one must consider that
an increase in health expenditure means that it is
necessary to revise the levels of efficiency in order
to optimize the use of scarce resources3.
For the case of various Latin American coun-
tries, the health sector is not actually included
among the priorities for public expenditure. In this
regard, health expenditures for these countries
have presented a serious deterioration in recent
years accentuated by the commencement of the
crises that began in the 1980's, sinc which time the
allocated resources have not followed the trends of
total real government expenditure19.
This study aimed fundamentally to develop
and implement a system for the monitoring of
costs that would identify the cost of case manage-
ment for each specific disease, and which could be
used to validate and develop a methodologic bud-
get in order to obtain the cost for specific disease
in developing countries, taking for analysis two
chronic-degenerative diseases and two infectious-
contagious diseases.
Material and Methods
This transversal study was conducted in a
nationally-recognized general hospital, located in
S. Paulo, Brazil, and adapted the criteria of
Kessner for the determination of tracers14,15. After
reviewing several studies on the cost of health ser-
vices1,5,9,22, a system of monitoring was applied to
four selected diseases: breast cancer, enteritis, car-
diac valve disease and bronchopneumonia.
The retrospective analysis was conducted
through the selection of 120 hospital records. In
accordance with the natural history of the diseases
under study, seven previously designed instru-
ments of data collection were applied to each of
the records for the purpose of determining the
standard procedures for the average case manage-
ment. In addition, a multidisciplinary team (physi-
cians, an economist, administrators, a nurse, and
an epidemiologist) utilized the Delphi technique to
arrive at a consensus regarding the identification
of the procedures, functions of production and
kinds of input that are involved in the process of
case management. Further, this interdisciplinary
team discussed the seven instruments and correc-
ted those aspects neccesary to take into account
the kinds of input, functions of productions and
products, as well as all the activities before and
after each function of production. During this
stage, the physicians played the fundamental role
in determining the different types of health inter-
ventions and the quality of the same.
These seven instruments include categories
such as: infrastructure, human resources, laborato-
ry and diagnostic studies, average length of stay in
hospital, special therapy, disposable material, cur-
ing material, drugs, general and support services.
The forward analysis consisted of a shadow
study of ten cases to validate the information
provided by the multidisciplinary team with
regard to the functions of production and the
inputs required to satisfy the demand for each
intervention.
Once the instruments were validated, the infor-
mation necessary for the determination of the uni-
tary cost and the average cost per case manage-
ment was collected.
Finally, the cost matrixes by disease were
designed in a computer package, the same one that
integrated the health information system of the
hospital.
Results
As the primary result of this study, a validated
methodological approach was obtained for the
determination of the cost of case management
(Table) and the calculation of the costs of the func-
tions of production of health services in develop-
ing countries (Fig. 1).
The average cost information was obtained
from the monitoring system. In the case of patients
with cardiac valve disease (Fig. 2), the total cost of
US$3,456.00 was determined for case manage-
ment. These costs were distributed in the following
manner: human resources (14.41%), laboratory and
diagnostic tests (3.88%), drugs and solutions
(1.52%), waste material and surgical (71.51%),
other costs (8.68%). For patients with breast cancer
(Fig. 3), a cost of US$1,646.00 was determined for
case management. These costs were distributed in
the following manner: human resources (29.85%),
laboratory and diagnostic studies (7.84%), drugs
and solutions (16.69%), special therapy (12.76%),
waste material and surgical (13.23%), other costs
(19.63%). For patients with bronchopneumonia
(Fig. 4), a total cost of US$1,056.00 was deter-
mined for case management. These costs were dis-
tributed in the following manner: human resources
(44.02%), laboratory and diagnostic studies
(4.04%), drugs and solutions (1.13%), waste mate-
rial and surgical (4.6%), other costs (46.21%). For
patients with chronic enteritis (Fig. 5), a total cost
of US$2,220.00 was determined for case manage-
ment. These costs were distributed in the following
manner: human resources (41.50%), laboratory and
diagnostic studies (3.67%), drugs and solutions
(6.88%), waste material and surgical (11.29%),
other costs (36.66%).
Discussion and Conclusions
We must consider overall that this was a case
study and that absolute data cannot be generalized
in this type of study where the cost of the inputs
will vary considerably even within the same insti-
tution. Nevertheless, the relative frequencies will
be able to be replicated to any hospital or geo-
graphical location. The methodology of analysis is
based fundamentally on the determination of dis-
ease specific costs apart from the natural history of
the disease and is supported not only by groups of
experts, but is also based on hospital records and
the universal bibliography for each disease.
It may be concluded that there were three cost
elements of greater relative weight in relation to
the total cost for case management: human
resources, waste material and surgical, as well as
the cost of the bed per day.
Those findings could, in some sense, were
expected if we consider, overall, that the human
resources per hour is one of the critical inputs of
medical care. The same occured in the case of
waste material and surgical, as well as the cost of
daily maintenance hospital. One must also take
into account that the costs calculated were referred
strictly to the direct cost of the hospital care.
According to other authors, this triad represents
the most important cost factor in the evaluation of
hospital costs.
The findings that were not expected and that
called our attention were relating to cardiac valve
disease. The relatively most costly elements were
waste material and surgical. The explanation of
this is due to the high cost of medical prosthesis
and waste material utilized in the intervention.
In relation to the total cost of standard case
management, it is interesting to observe that the
major cost corresponded to cardiac valve disease
second only to enteritis. The previous called the
attention to the fact that it was expected that the
two chronic degenerative diseases were the most
costly, however, breast cancer resulted in lower
costs than enteritis. On the other hand, in compa-
ring the total cost of the two chronic and the two
infectious diseases, if is possible to observe that
the cost of the former is practically double that of
the latter.
The results of the study support the conclusion
that in the short, medium and long term internal
competition will be generated between chronic
and infectious diseases in the use of the resources
allocated to the health sector. Overall, if we take
into account the assigned health care budget, the
changes in the epidemiological profile are charac-
teristic of any developing country. On the other
hand, this methodological development and the
implementation of systems to monitor costs allow
the understanding of the different factors in cost.
They generate information of high quality in the
determination of charges for differential quotas, in
the increase of productivity, in the search for new
alternatives of financing and above, in the making
of rational decisions by health care planners.
Finally, a very important result in this type of
study is the need for the training of medical per-
sonnel in health economics and the study of this
problem from an interdiscliplinary approach.
Together an interdisciplinary team contributes a
great deal to the needed and urgent incorporation
of health economics in the analysis and solution of
health care problems in developing countries. In
this sense, the results of this study can lead to the
creation of systems of monitoring costs that sup-
port decision making process. The cost centers
integrated into the hospital information systems, a
posteriori, will be the fundamental basis for the
analysis of cost-effectiveness, cost-efficiency, and
cost-benefit of the distinct alternatives of interven-
tion for the diseases under study.
In speaking of the financing perspectives for
the production of health services, the challenges
that health policies generate must be emphasised:
including the process of integration of health ser-
vices and the process of the public-private mix in
the generation of services.
In order for the social investment in health to
generate its maximum potential, and to combat the
problems of equity, quality, accessibility, and effi-
ciency, it is necessary to avoid the dispersal of
investments. A paradoxical result demonstrates
that this investment can have the "perverse effect"
of reproducing the status quo rather than reducing
social inequalities. That is exactly what occurs in a
social system such as characterizes a country in
which the fundamental concerns relate to the occu-
pational and economic bases. In this sense, for
national health systems, the search for viable for-
mulas for integrating the providing of services
constitutes a challenge and consequently, one of
the most urgent tasks in the effective construction
of a national health system which strives to attain
its social objective.
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Resumo
São estudados os resultados de parte da necessidade de se desenvolver métodos para a análise de custos em países
em desenvolvimento, principalmente na região da América Latina. Pretendeu-se gerar conhecimento a partir de uma
avaliação econômica, para apoiar a tomada de decisões na organização de sistemas de saúde, particularmente no
uso eficiente dos recursos destinados aos serviços médicos. Foram seleccionadas duas doenças crônicas (câncer de
mama e valvulopatia) e duas infecciosas (enterite e broncopneumonia), para serem estudadas. Os resultados
permitiram recomendar o uso da metodologia validada para a análise econômica de custos de qualquer outra doença
que se necessite estudar, bem como o uso da informação para tomar decisões.
Custos de cuidados de saúde. Controle de custos.
